Nov 15 2024
A new systematic review from Utrecht University in the Netherlands explores the potential of minor cannabinoids in treating psychiatric disorders. Published in European Neuropsychopharmacology, the study offers fresh insight into how these lesser-known compounds might aid in addressing conditions such as anxiety, depression, and addiction. The research highlights the growing interest in cannabinoids for mental …
Nov 14 2024
Researchers at University Hospital of the Technical University of Munich have found that cannabidiol (CBD) may help protect lung endothelial cells from the harmful side effects of radiation, which they outline in a new study. Published in the journal Cancers, the study investigated CBD’s ability to shield the lung’s microvasculature from oxidative stress and inflammation …
Nov 13 2024
A new study conducted by researchers from Augusta University and The University of Texas Health Science Center at Houston has found that cannabidiol (CBD) may serve as a promising, cost-effective treatment for Alzheimer’s disease (AD). Published in the International Journal of Molecular Sciences, the study suggests that inhaled CBD could help improve cognitive function and …
Nov 07 2024
A study published in Plastic and Reconstructive Surgery has found that marijuana use does not significantly impact outcomes in breast reduction surgeries. Conducted by researchers from the University of Pennsylvania and NYU Langone, the study aimed to clarify whether marijuana use might influence surgical outcomes or quality of life (QoL) post-surgery, as marijuana use continues …
Nov 02 2024
A new study published in AJOB Neuroscience reveals that most Americans support psilocybin use under supervision, with broad bipartisan backing for both mental health treatment and general well-being enhancement. Psilocybin, the psychedelic compound found in “magic mushrooms”, remains classified as a Schedule I substance in the U.S., making it illegal for all uses, despite numerous …
Oct 31 2024
According to a newly published meta-analysis, “psilocybin is superior in treating depression compared to established psychotherapy alone used for treating depression.” Published in the Journal of Psychopharmacology, the study was conducted by researchers from Alborz University of Medical Sciences, Tehran University of Medical Sciences, and Shahid Beheshti University of Medical Sciences, all in Iran. “Due …
Oct 30 2024
A new study from Colombia’s Universidad de Antioquia, published in the peer reviewed journal Medical Cannabis and Cannabinoids, highlights CBD-rich oil as a treatment option for neuropsychiatric symptoms (NPS) in Alzheimer’s disease (AD). In a two-year prospective study, researchers observed that a majority of patients experienced significant improvements in symptoms and a reduction in caregiver …
Oct 30 2024
A study published in the peer reviewed journal Medical Cannabis and Cannabinoid and e-published by the National Library of Medicine reveals promising findings on the impact of high-THC marijuana on PTSD symptoms. The real-world, observational study examined 58 UK civilians who had prior cannabis experience and a confirmed PTSD diagnosis, with data sourced from the …
Oct 29 2024
A new study highlights the potential of cannabis-derived compounds as effective agents against multidrug-resistant (MDR) bacterial infections. The study is being published in the upcoming issue of the European Journal of Microbiology and Immunology, and it was published online ahead of print by the U.S. National Library of Medicine. “The number of human infections with …
Oct 29 2024
A study, published in Molecular Psychiatry, led by Professor Bernard Lerer from the Department of Psychiatry at the Hadassah—Hebrew University Medical Center shows promising results for using psilocybin as a potential treatment for obsessive-compulsive disorder (OCD) and Tourette’s syndrome. The study, titled “Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the …
